Clinical Trial Update: A Prospective, Randomized, Multicenter Study of Comparison of TACE Combination With and Without EBRT for Hepatocellular Carcinoma With Portal Vein Tumor Thrombi [Phase 3]

View source ↗

Summary

Phase 3 randomized trial evaluating TACE with or without EBRT for hepatocellular carcinoma with portal vein tumor thrombi; status and results not disclosed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Carcinoma, Hepatocellular | Phase 3 | Status: UNKNOWN